Hi mate,
I hear your frustrations, as do a lot of us that have been holding since IPO/2017...Don't forget that G Med team laid out plans based on timings proposed by way of Green channel etc, add to that Trump and his Trumpiness along the way, CFDA being replaced by NMPA. Yacov has been consistent with the lack of released details and has a more left of field approach, 50% of the time due to a lot of the certification process being out of his hands, the other 50% he doesn't want too much info out there for competitors to take away his golden goose.
You may have saw that I topped up the other day and could have been crazy, foolish or both, but i'm still a big time believer and long (3+ years) term holder.
The 4C will (should) reveal a lot, and the CFDA progress is the only back scratch we need to release this monster.
IMO & good luck
- Forums
- ASX - By Stock
- GMV
- GMV The Future
GMV The Future, page-324
-
- There are more pages in this discussion • 2,690 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online